Skip to main content
Clinical Trials/TCTR20190121001
TCTR20190121001
Completed
Phase 1

Parent-child interaction therapy for aggression in children of caregiver with cancer, a double-blind randomized controlled trial

none0 sites50 target enrollmentJanuary 21, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
none
Enrollment
50
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 21, 2019
End Date
October 1, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria were: 1\) age range of 5\-7 years in children; 2\) the diagnosis of metastatic cancer stage 4 in at least one parent or caregiver; 3\) the diagnosis of dependence to cannabis with a given dose by caregiver; 4\) the diagnosis of aggression syndrome in two clinical domains and evaluation of questionnaires

Exclusion Criteria

  • The exclusion criteria for mothers and children were as follow: 1\) lack of natural intelligence with a criterion of less than 70; 2\) use of psychiatric medications due to the possible effect on the psychological syndrome.

Outcomes

Primary Outcomes

Not specified

Similar Trials